News Center

Home page

Peak Report

News reports

Announcement of Jianfeng Group Lin2017 -008 on Providing Guarantee to Holding Subsidists

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-008

Bond Abbreviation: 13 Peak 01 Bond Code: 122227

Bond Abbreviation: 13 Peak 02 Bond Code: 122344

Announcement of Zhejiang Jianfeng Group Co., Ltd.

Providing Guarantees to Holding Subsidiaries

The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .

Important Content Tips

● Names of Guarantees: Zhejiang Jianfeng Pharmaceutical Co., Ltd., Daye Jianfeng Cement Co., Ltd., Zhejiang Jianfeng International Trade Co., Ltd.

● Proposed guarantee amount: set guarantee amount 4.3 .9 billion yuan.

● Is there any counter-guarantee in this guarantee: No

● Cumulative number of overdue external guarantees: No

Overview of 1. guarantees

2017 On April 15, 39, Zhejiang Jianfeng Group Co., Ltd. held the 11th meeting of the 9th Board of Directors, and all eight directors of the company attended the meeting in person; comply with the relevant provisions of the "Company Law" and the "Articles of Association" of the company, and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the "Proposal on Providing Guarantees for Holding Subsidiaries" was reviewed and passed with 8 votes in favor, 0 votes against, and 0 abstentions.

This motion needs to be submitted to the general meeting of shareholders for consideration.

Basic Information of 2. Guarantees

, Zhejiang Jianfeng Pharmaceutical Co., Ltd., with a registered capital of 19853 yuan, of which: the company accounts for 99.16 percent, and its registered address is the second floor of X02 Office Quality Inspection Building, No. 58 Gaofan Section, Baitang Downline, Wucheng District, Jinhua City, Zhejiang Province. Its main business is drug research and development and production (operated with valid licenses); import raw materials for production and scientific research; import machinery and equipment, instruments and spare parts. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments).

, daye peak cement co., ltd. has a registered capital of 2.5 .1 billion yuan, of which the company accounts for 6% and the company's holding subsidiary Zhejiang peak cement co., ltd. (the company holds 95.25) accounts for 70%. registered address: daye city hubei province security town; main business: cement, cement clinker, cement mechanical and electrical equipment manufacturing and sales; building materials products such as sales.

, Zhejiang Jianfeng International Trade Co., Ltd., with a registered capital of 3000 yuan, of which: 93.33 of our company and 6.67 of Jianfeng Pharmaceutical Co., Ltd., registered address: 88 changchun West Road, Jindong Economic Development Zone, Zhejiang Province, mainly engaged in self-management and agency of import and export of various commodities and technologies, engaged in processing of imported materials and "three to one supplement" business; To carry out countertrade and re-export trade, warehousing of bonded and general goods (except dangerous goods), pharmaceutical intermediates, pharmaceutical equipment, etc.

Audited key

financial data of the above subsidiaries 2016 (in: ten thousand yuan)

company name	total assets	total liabilities	total bank loans	total current liabilities	net assets	total operating income	net profit attributable to parent company owner
daye peak cement co., ltd.	52910.68	13875.37		13803.94	39035.31	48836.56	5273.45
Zhejiang Jianfeng Pharmaceutical Co., Ltd.	107327.91	64705.62	3400	58149.59	42622.29	122399.97	4528.59
Zhejiang Jianfeng International Trading Co., Ltd.	6537.97	5285.42	0	5172.92	1252.55	15089.31	169.39

Main Contents of Guarantee Provided by 3.

, to Holding Subsidiary provide guarantees for loans from financial institutions, set the following limits:

Guaranteed Unit	Set Guarantee Limit (RMB 10,000)
Daye Jianfeng Cement Co., Ltd.	5000
Zhejiang Jianfeng Pharmaceutical Co., Ltd.	30000
Zhejiang Jianfeng International Trade Co., Ltd.	8000
Total	43000

, agreed to be Zhejiang Jianfeng International Trade Co., Ltd. Letter of Guarantee from the Company, provide corresponding guarantee for the goods stored in the company by the customers of Zhejiang Jianfeng International Trade Co., Ltd.

The guarantee within the above amount is authorized to be executed by the chairman of the board of directors.

4. the opinion of the board of directors

The above guaranteed companies are all controlling subsidiaries of the company. The company can effectively control the guarantee risks, and the board of directors agrees to the above guarantees.

# The three independent directors of the 296 company issued independent opinions on the matter and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.

5. Cumulative Number of External Guarantees and Number of Overdue Guarantees

As of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 12.5

.3 billion yuan, accounting for 52.4 of the total owner's equity attributable to the parent company by the audited consolidated caliber at the end of 2016. Among them, the total amount of approved guarantee for the controlling subsidiary is 650 million yuan, accounting for 27.25 of the total owner's equity attributable to the parent company's audited consolidated caliber at the end of 2016.

As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries (excluding subsidiaries) was 5.77

.6 billion yuan, accounting for 24.17 of the total owner's equity attributable to the parent company by the audited merger at the end of 2016. The actual balance of the company's guarantee to the controlling subsidiary is 25 million yuan, accounting for 1.05 of the Company's total audited consolidated equity attributable to owners of the parent company at the end of 2016.

As of the disclosure date of this announcement, the company has no overdue guarantee.

6. Reference Document Catalogue

Resolution of the 11th

Meeting of the 9th Board of Directors of the Company;

hereby announce

Zhejiang Jianfeng Group Co., Ltd.

Board of Directors

April 18, 2017

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页